More recently, needle free sublingual vaccination with MVA and gp120 was found to induce HIV specific immune responses against multiple HIV-1 clades that significantly delayed acquisition of SHIVSF162P3 infection which correlated with V2 specific antibody responses10. Here, ITIH4 is linked to infection.